This inventor holds 1 USPTO granted patent. Top assignee: Vanderbilt University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Kelly Meyers: Innovator in Cancer Treatment
Introduction
Kelly Meyers is an accomplished inventor based in Gallatin, TN (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of monoclonal antibodies.
Latest Patents
Meyers holds 1 patent for his invention titled "Methods of using an antibody to inhibit WNT-mediated signaling in cancer." This patent focuses on monoclonal antibodies and fragments directed to LRP5/6, which are instrumental in the prevention and treatment of cardiac remodeling and cancer. The methods disclosed in this patent provide new avenues for combating these serious health issues.
Career Highlights
Kelly Meyers is affiliated with Vanderbilt University, where he continues to advance his research in the medical field. His work has garnered attention for its potential impact on cancer therapies and treatment methodologies.
Collaborations
Meyers collaborates with notable colleagues, including Ethan Lee and Pampee P Young, who contribute to his research efforts and enhance the scope of his work.
Conclusion
Kelly Meyers is a pioneering inventor whose work in monoclonal antibodies is paving the way for innovative cancer treatments. His contributions to the field are invaluable and hold promise for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile